Home » Topics » BioWorld Science

BioWorld Science
RSS

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Alnorin reported in phase I

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

CB-30865 selected for further study

April 19, 1996

Onconase development update

April 19, 1996

Terramed receives patent protection for vaccine technology

April 19, 1996

CellCept available in Europe

April 19, 1996

Androgel-DHT in phase II for AIDS indications

April 19, 1996

TNF-bp in clinical testing

April 19, 1996

GEM-91 + AZT enters clinical trials in Europe

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...